LENZ smart money
Lenz Therapeutics, INC. (LENZ): 3 insider buys, 1 top fund holding it, 1 ETF change in the public filings.
Insider buys, 12 months$555k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-03-30 | Schimmelpennink Evert B. | President, CEO and Secretary | $251k | $8.95 |
| 2026-03-30 | Chevallard Daniel R. | Chief Financial Officer | $64k | $8.57 |
| 2025-11-10 | Mccollum James W | Director | $239k | $22.79 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 31 | Affinity Asset Advisors, LLC | ADD +200% | 0.07% | $1M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| Ishares U.S. Pharmaceuticals ETF | SELL | −$600k | 2026-06-30 |